Pan‐cancer analysis identifies <scp> <i>CD300</i> </scp> molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia-Reference-Cited by-同舟云学术

Pan‐cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia

Published:2022-05-31 Issue:1 Volume:12 Page:789-807
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Xu Zi‐jun¹²³,Jin Ye²⁴,Zhang Xin‐long⁵,Xia Pei‐hui¹²³,Wen Xiang‐mei¹²³^ORCID,Ma Ji‐chun¹²³,Lin Jiang¹²³,Qian Jun²⁵^ORCID

Affiliation:

1. Laboratory Center Affiliated People's Hospital of Jiangsu University Zhenjiang Jiangsu People's Republic of China

2. Zhenjiang Clinical Research Center of Hematology Zhenjiang Jiangsu People's Republic of China

3. The Key Lab of Precision Diagnosis and Treatment in Hematologic Malignancies of Zhenjiang City Zhenjiang Jiangsu People's Republic of China

4. Department of Hematology Affiliated People's Hospital of Jiangsu University Zhenjiang Jiangsu People's Republic of China

5. Department of Hematology The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University Danyang Jiangsu People's Republic of China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4905

Reference65 articles.

1. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

2. Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

3. Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma

4. Mechanisms of Immune Tolerance in Leukemia and Lymphoma

5. Immune evasion mechanisms in acute myeloid leukemia: A focus on immune checkpoint pathways

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CD300e: Emerging role and mechanism as an immune-activating receptor;International Immunopharmacology;2024-05

2. Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer;Frontiers in Immunology;2024-03-05

3. PHF6 loss reduces leukemia stem cell activity in an acute myeloid leukemia mouse model;Cancer Cell International;2024-02-09

4. Comprehensive characterization of TGFB1 across hematological malignancies;Scientific Reports;2023-11-04

5. Adjuvantation of whole-killed Leishmania vaccine with anti-CD200 and anti-CD300a antibodies potentiates its efficacy and provides protection against wild-type parasites;Molecular Immunology;2023-11